Experts in Clinical Oncology
Unparalleled Canadian Oncology Experience
We attract cutting-edge oncology trials to Canada by providing 50% quicker site start-up times to small & mid-sized biopharma companies
What We Do
Founded in 1997, we are a niche CRO with a singular focus in oncology clinical trials (Phase 1, 2 & Phase 3). With privileged site relationships across Canada we help small & mid-sized biopharma clients achieve the following study activities.
Our proven track record bundled with 25 years of lessons learned provides our mid-size and smaller biotech sponsors a Multi Niche Web™ of specialized experts who work in tandem with Scimega to achieve exceptional results.
Each study is unique, and in every case we seamlessly integrate the trial study plan and bring key mitigating actions and solutions throughout the study. This is done with no added administrative or logistic burden to the companies we serve with the following study activities.
Site Selection &
Accelerated Study
Start-Up
Health Canada
Regulatory
Strategy
Provincial Ethics
Approval Strategy
(IRB/REB)
Clinical
Monitoring
Country
Oversight
REVERSE FEASIBILITY PROGRAM
A powerful approach to feasibility assessment that is proven to accelerate start-up by connecting sponsors with a network of top performing Canadian oncology investigators.
